Diagnosis and treatment of поп-ulcerative dyspepsia syndrome

Содержание

Слайд 2

Dyspepsia syndrome is determined as pain or discomfort localized in the epigastric

Dyspepsia syndrome is determined as pain or discomfort localized in the epigastric
area closer to the medial line. Pains localized in the right and left subcostal areas are not regarded as dyspepsia syndrome. A complex of individual unpleasant symptoms being identified as weight and repletion in the epigastrium, as well as nausea and early saturation but not pain, are recognized as the discomfort.

Слайд 3

Patients' complaints on admission corresponding to the complex of symptoms in gastric

Patients' complaints on admission corresponding to the complex of symptoms in gastric
dyspepsia:

pains in the epigastric area
gastroesophageal regurgitation and epigastric burning (heartburn)
anorexia, nausea and vomiting
early saturation during the meals
a feeling of «heavy stomach» in the epigastric area
meteorism, eructation, aerophagia (air swallowing).

Слайд 4

A complex of symptoms in dyspepsia syndrome is to be distinguished from

A complex of symptoms in dyspepsia syndrome is to be distinguished from
the one in gastroesophageal reflux (heartburn and burning pains in the area of xiphoid process predominate) or in irritated intestine syndrome (pains are associated with defecation and accompanied with disturbances in defecation frequency and stool consistence).

Слайд 5

Depending on the causes triggering dyspeptic disorders, there is organic and functional

Depending on the causes triggering dyspeptic disorders, there is organic and functional (non-ulcerative) dyspepsia.
(non-ulcerative) dyspepsia.

Слайд 6

Organic dyspepsia is recognized if the following markers are highlighted:

esophageal disease: reflux-

Organic dyspepsia is recognized if the following markers are highlighted: esophageal disease:
esophagitis
gastric disease: ulcer, cancer, gastritis
other GIT diseases: chronic pancreatitis, Crohn's disease, pancreas cancer, colon cancer
other organ's diseases: cardiac, renal, hepatic insufficiency, Addison's disease, toxic goiter, diabetes mellitus, hypo- and hyperthyroidism, hyperparathyroidism
drug therapy: non-steroid anti-inflammatory drugs, cardiac glycosides, antibiotics
other causes: alcohol abuse, pregnancy, psychic disorders, depressions, neuroses

Слайд 7

If to exclude the diseases mentioned after a through examination, the patients

If to exclude the diseases mentioned after a through examination, the patients
(in case the dyspeptic complaints proceed more than 12 weeks, roughly a year) are considered to have the syndrome of non-ulcerative dyspepsia.

Слайд 8

Classification of functional dyspepsia.

According to A. Smout et al. (1992)
- according

Classification of functional dyspepsia. According to A. Smout et al. (1992) -
to intestinal motility: gastric motility disorders, pylorus motility disorders, gastroparesis, coordination disturbance between stomach and duodenum; - according to evacuation from the stomach: delayed evacuation, accelerated evacuation

Слайд 9

According to N. Talley (1991), M. von Oytryve et al. (1993)
- ulcerative-like

According to N. Talley (1991), M. von Oytryve et al. (1993) -
variant;
- refluxoid variant;
- dyskinetic variant;
- non-specific variant.

Слайд 10

In 20-69% of patients with ulcerative-like variant the duodeno-gastric reflux, delayed

In 20-69% of patients with ulcerative-like variant the duodeno-gastric reflux, delayed evacuation
evacuation from the stomach, and time prolongation during the passage within the small intestine are to occur. More than a half of patients with dyskinetic variant express poor stomach motility. At the same time, some patients with functional dyspepsia present no harmful changes in motility of esophagus, stomach and duodenum.

Слайд 11

Clinical variation of non-ulcerative dyspepsia.

Depending on the either symptoms predominated in the

Clinical variation of non-ulcerative dyspepsia. Depending on the either symptoms predominated in
clinical presentation of non-ulcerative dyspepsia syndrome, ulcerative-like and dyskinetic variants are distinguished.

Слайд 12

Clinical characteristics of various non-ulcerative dyspepsias

Ulcerative-like type
Pains localized in the epigastric

Clinical characteristics of various non-ulcerative dyspepsias Ulcerative-like type Pains localized in the
area
Pains subside soon after taking antacids
Hunger pains
Nocturnal pains
Recurring pains

Слайд 13

Dyskinetic type

Early saturation
Feeling of repletion in the epigastria area after the meals
Nausea
Upper

Dyskinetic type Early saturation Feeling of repletion in the epigastria area after
tympania
Feeling of discomfort, exaggerating after the meals

Слайд 14

If the symptoms presented in patients do not correspond with the underlined

If the symptoms presented in patients do not correspond with the underlined
variants, then the symptoms are to be associated with non-specific variant of non­ulcerative dyspepsia. A combination of non-ulcerative dyspepsia with gastro­esophageal reflux disease and irritated intestine syndroms are also possible.

Слайд 15

Etiology and pathogenesis

Chronic gastritis usually associated with pyloric helicobacterium (H. pylori),

Etiology and pathogenesis Chronic gastritis usually associated with pyloric helicobacterium (H. pylori),
used to be recognized as the cause for dyspeptic disorders, if no signs of ulcerative disease, stomach cancer, cholelithiasis, etc. were revealed in patients with dyspepsia syndrome. However, recent investigations showed lack of correlation between changes in gastric mucous membrane and dyspeptic complaints, and a massive amount of patients with chronic gastritis feel quite sound.

Слайд 16

Chronic gastritis associated with H. pylori is frequently revealed in patients with

Chronic gastritis associated with H. pylori is frequently revealed in patients with
non-ulcerative dyspepsia syndrome. H. pylori eradication (suppression) resulted in inflammatory process suppression in the gastric mucous membrane, however, it didn't favour the disappearance of dyspeptic complaints in most of patients.

Слайд 17

The recent findings have also exposed the lack in distinction concerning the

The recent findings have also exposed the lack in distinction concerning the
hydrochloric acid secretion in health and disease. No patients having smoking habits, alcohol abuse, tea and coffee preferences, as well as non-steroid
anti-inflammatory drugs were noted among the mentioned category in comparison with those ones with other gastrointestinal diseases.

Слайд 18

Gastric and duodenal motility disorder proved to be the chief pathogenetic factors

Gastric and duodenal motility disorder proved to be the chief pathogenetic factors
of non-ulcerative dyspepsia syndrome. There is a link between the definite dyspeptic complaints and specific motility disorders in the upper parts of gastrointestinal tract

Слайд 19

Correlation of various pathological and physiological mechanisms of functional dyspepsia with clinical

Correlation of various pathological and physiological mechanisms of functional dyspepsia with clinical symptoms.
symptoms.

Слайд 20

Gastric accommodation disorder (accommodation is determined here as capability of the fundic

Gastric accommodation disorder (accommodation is determined here as capability of the fundic
part of the stomach to relax after food absorption) observed in 40% of patients with non-ulcerative dyspepsia, results in disturbances to distribute the food in the stomach and early saturation as well.

Слайд 21

Gastric accommodation disorder (accommodation is determined here as capability of the fundic

Gastric accommodation disorder (accommodation is determined here as capability of the fundic
part of the stomach to relax after food absorption) observed in 40% of patients with non-ulcerative dyspepsia, results in disturbances to distribute the food in the stomach and early saturation as well.

Слайд 22

If stomach evacuates the food well, the cause for the dyspeptic complaints

If stomach evacuates the food well, the cause for the dyspeptic complaints
is a heightened sensibility of stomach receptors on the walls to extension (so-called, visceral hypersensitivity).

Слайд 23

Diagnosis and differential diagnosis.

A complex of symptoms in non-ulcerative dyspepsia is of

Diagnosis and differential diagnosis. A complex of symptoms in non-ulcerative dyspepsia is
no specific ground, therefore, the diagnosis making is based on the exclusion of those diseases, which are of organic dyspepsia origin (firstly, ulcerative disease, stomach ulcer, gastroesophageal reflux disease, cholecystitis and pancreatitis).

Слайд 24

It is essential to take into account secondary motility derangement of the

It is essential to take into account secondary motility derangement of the
upper parts of the GIT (for example, in diabetes mellitus, Addison's keloid, systemic scleroderma).

Слайд 25

The syndrome of gastric dyspepsia in ulcerative disease characterizes with response on

The syndrome of gastric dyspepsia in ulcerative disease characterizes with response on
food, seasonal character of exacerbation in many patients. Structurally, the syndrome resembles the one in chronic gastritis. Ulcerative stomach disease characterizes with epigastralgia after the food. Time of its origin is noticed to depend on ulcer localization: the lower ulcer is, the later pain occurs. Ulcers of antral part of the stomach resemble those of ulcerative disease of the duodenum.

Слайд 26

stomach ulcer

The diagnostical method of stomach ulcer is an X-ray examination. But

stomach ulcer The diagnostical method of stomach ulcer is an X-ray examination.
in some cases, ulcers may not be revealed, then gastroscopy is to be applied.

Слайд 27

Stomach cancer

Stomach cancer is manifested by gastric dyspepsia, which characterizes with persistence

Stomach cancer Stomach cancer is manifested by gastric dyspepsia, which characterizes with
and progression. The gastric dyspepsia is not associated with the food. Most of patients express the whole range of signs, such as, nausea, appetite loss, even anorexia, «bursting» and weight in the epigastrium, vomiting after food intake.
Some patients may develop gastric dyspepsia followed by stomach cancer. Therefore, the correlation between diet violence, gastric dyspepsia and cancer disappears.

Слайд 28

chronic cholecystitis

Dyspeptic complaints have a more frequent occurrence during the chronic cholecystitis

chronic cholecystitis Dyspeptic complaints have a more frequent occurrence during the chronic
development. Vomiting is presented in 30-50% of patients. In association with hypotonic dyskinesia of the gall bladder, pain and a feeling of weight in the right hypochondrium subside after vomiting.

Слайд 29

During the period of exacerbation, patients complain of nausea, bitter taste, eructation

During the period of exacerbation, patients complain of nausea, bitter taste, eructation
with bitter. Due to the development of secondary duodenitis, gastritis, pancreatitis, enteritis the following signs are presented: heartburn, eructation with «rotten», meteorism, appetite loss and diarrhea.

Слайд 30

pancreatic dyspepsia

is expressed in exacerbation or severe course of the disease. It

pancreatic dyspepsia is expressed in exacerbation or severe course of the disease.
is manifested by:
eructation with air (aerophagia) or food eaten;
nausea, vomiting;
appetite loss;
fat food rejection;
tympania;
hypersalivation.

Слайд 31

Gastric dyspepsia in chronic gastritis

is characterized with the dependency on diet violence.

Gastric dyspepsia in chronic gastritis is characterized with the dependency on diet
It is presented by tympania and pressure discomfort in the epigastrium, as well as eructation, soon regurgitation. Nausea and vomiting are sometimes to occur. Beside gastric dyspepsia, chronic gastritis is manifested by pains in the epigastrium appeared soon after food intake. Food consistence and character are also of importance.

Слайд 32

As the disease progresses, patients with chronic gastritis have tendency to hyposecretion

As the disease progresses, patients with chronic gastritis have tendency to hyposecretion
and reduction in acidity of gastric juice, in some pronounced case the achylic syndrome appears.

Слайд 33

Antral gastritis, gastroduodenitis may resemble ulcerative disease of the duodenum in their

Antral gastritis, gastroduodenitis may resemble ulcerative disease of the duodenum in their
clinical manifestations. The disease is frequently accompanied with dyskinesia of biliary and pancreatic ducts and intestines. Gastroscopy and biopsy are essential in contemporary requirements while diagnosing chronic gastritis (it is a clinical morphological diagnosis).

Слайд 34

Gastroesophageal reflux disease

is a chronic recurrence conditioned by retrograde entrance of

Gastroesophageal reflux disease is a chronic recurrence conditioned by retrograde entrance of
food mass into esophagus. Dyspeptic manifestations include the following:
Heartburn is recognized as a severe burn in the substernal area, which irradiates upward from xiphoid process. It is accompanied by the reduction of pH in the esophagus lower than 4.0. It is common to bee triggered by a definite food intake, overfeeding, forward incline, physical activity, horizontal position, alcohol and smoking.

Слайд 35

Pains in the epigastrium associated or not with the food taken may

Pains in the epigastrium associated or not with the food taken may
occur quite often.
Vomiting is observed more frequently in comparison with ulcerative or duodenal disease.
Eructation is accompanied by a bitter or acid feeling in the mouth. Both heartburn and eructation bother mostly in level position and forward inclinations.

Слайд 36

Methods of differential diagnosis applied in functional dyspepsia.

Esophagogastroduodenoscopy
X-ray examination
Ultrasonography
Intragastric and intraesophageal monitoring

Methods of differential diagnosis applied in functional dyspepsia. Esophagogastroduodenoscopy X-ray examination Ultrasonography
of pH
Manometry of the lower esophageal sphincter
Electrogastrography
Test course for drug therapy (4-8 weeks)

Слайд 37

Clinical and biomedical blood tests, as well as ultrasound investigations of the

Clinical and biomedical blood tests, as well as ultrasound investigations of the
abdomen, gastroduodenoscopy and X-ray examination with barium sulfate (ifindicated), computed tomography are carried out.
If no symptoms denoting motility disorder of the upper parts of the GIT are detected, then electrogastrgraphy, gastric scintigraphy (gamma camera) with technetium and indium isotopes are applied.

Слайд 38

It is supposed to be important to take alarm symptoms or «red

It is supposed to be important to take alarm symptoms or «red
flags» into account while making the diagnosis of non-ulcerative dyspepsia. Their presence excludes the diagnosis of non-ulcerative dyspepsia and requires a more profound and thorough diagnostic search to reveal some serious organic disorders.

Слайд 39

Alarm symptoms are characterized as follows:

fever
anemia
dysphagy
leukocytosis
visible admixture
accelerated ESR
blood in feces
dyspepsia symptoms occurred

Alarm symptoms are characterized as follows: fever anemia dysphagy leukocytosis visible admixture
over the age of 45
weight loss

Слайд 40

Treatment.

The treatment procedures are to be complex and include not only drug

Treatment. The treatment procedures are to be complex and include not only
administration, but also changes in patient's life style, regimen and feeding habits, psychotherapeutic methods. Common recommendations consist of frequent and partial feeding, heavy and fat food exclusion, smoking and alcohol arrest, non-stroid anti-inflammatory drugs.

Слайд 41

Antacidic and antisecretory drugs (H2-blockers and blockers of proton pump) are indicated

Antacidic and antisecretory drugs (H2-blockers and blockers of proton pump) are indicated
in ulcerative-like variant of functional dyspepsia.
T. Omeprasoli 20 мg 2 t. a day
Т. Qamateli 20 мg 2 t. A day

Слайд 42

Some patients (about 20-25%) may express positive response to anti-helicobacterial eradication therapy.

Some patients (about 20-25%) may express positive response to anti-helicobacterial eradication therapy.
The treatment may have insufficient effect for the vanishing of dyspeptic disorders, but the risk of ulcerative incidence reduces.

Слайд 43

Eradication therapy

T. Omeprasoli 20 mg 2 t. a day
T. Clarithromycini 500 mg

Eradication therapy T. Omeprasoli 20 mg 2 t. a day T. Clarithromycini
2 t. a dayC
T. Amoxicillini 1000 mg 2 t. a day

Слайд 44

The basic means of patients' treatment of a developing dyskinetic variant is

The basic means of patients' treatment of a developing dyskinetic variant is
supposed to be prokinetic drugs normalizing the motility of GIT. The blockers of dopamine receptor, such as, metodopramide (Gerucal) and domperidone (Motilium) are recognized in this group of drugs.

Слайд 45

The use of metodopramide (especially long-term one) may cause untoward and side

The use of metodopramide (especially long-term one) may cause untoward and side
effects in a great amount of patients (20-30%), which are the following:
drowse,
tiredness,
anxiety
extrapyramidal responses

Слайд 46

European Motilium investigations in non-ulcerative dyspepsia treatment at doses of 5-20 mg

European Motilium investigations in non-ulcerative dyspepsia treatment at doses of 5-20 mg
3-4 times a day during 3-4 weeks, revealed the reduction in complaints, i.e. from 61-85%). Simultaneously with the reduction of intensity in clinical symptoms, patients develop better evacuation from solid and fluid food.
Side effects in Motilium application are rare to appear (in 0.5-1.8%) of patients). Headaches, general exhaustion are frequently to be observed.

Слайд 47

Итомед (Itomed)
итоприда гидрохлорид
50 мг 3 раза в день
side effects:
-лейкопения,

Итомед (Itomed) итоприда гидрохлорид 50 мг 3 раза в день side effects:
тромбоцитопения,
гинекомастия, гиперпролактинемия;
диарея

Слайд 48

Cyzapride (propulside, coordinacs) attracts much attention. This drug is quite effective in

Cyzapride (propulside, coordinacs) attracts much attention. This drug is quite effective in
functional dyspepsia (in 60-90%> of cases). It is to be taken 15-40 mg in a day (5-10 mg 3-4 times a day) during 4 weeks. It should be noted that this drug is more effective in refluxoid, dyskinetic and non-specific forms of functional
dyspepsia. But it is less effective in ulcerative-like forms and has perspective action up to 6 months.
Имя файла: Diagnosis-and-treatment-of-поп-ulcerative-dyspepsia-syndrome.pptx
Количество просмотров: 31
Количество скачиваний: 0